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Background/aim: This study aimed to investigate the prevalence and association of mesenteric panniculitis (MP) with other diseases
and the clinicoradiological features of MP, and to examine computed tomography findings to estimate the presence of malignancy in
patients with MP.
Materials and methods: Between September 2012 and August 2016, we used a keyword search to identify patients diagnosed with MP.
Associated diseases and malignancies of patients were recorded. Cut-off values and diagnostic efficiencies of total MP scores and short
and long diameters of the greatest lymph nodes were determined.
Results: Out of 22,033 patients, 309 were determined to have MP (prevalence 1.40%); 57.9% of these patients had a malignancy and
42.1% did not have a malignancy. The mean total MP scores and diameters of the greatest lymph nodes were significantly higher in
the patients with a malignancy (P < 0.001). AUCs were 0.728, 0.879, and 0.767 for the short diameter, long diameter, and total score,
respectively. The diagnostic efficiencies of the long diameter of the greatest lymph nodes were significantly higher than the total MP
scores and the short diameter of the greatest nodes.
Conclusion: MP is thought to be associated with abdominal and other system malignancies so MP may be a paraneoplastic syndrome
in some patients.
Key words: Abdomen, computed tomography, malignancy, mesenteric panniculitis

1. Introduction
Mesenteric panniculitis (MP) is rare, chronic, idiopathic,
and nonspecific inflammation of the bowel mesentery
(1). Various terms have been reported in the literature
depending on the predominant component, such as
mesenteric lipodystrophy, sclerosing mesenteritis,
mesenteric Weber–Christian disease, and retractile
mesenteritis or mesenteric fibrosis (2). MP is histologically
characterized by variable degrees of fat necrosis, chronic
inflammation, and fibrosis (1). Although MP is usually
seen at the root of the small bowel mesentery, it can rarely
involve the large bowel mesentery, peripancreatic and
omental fat, retroperitoneal space, and pelvic fat (3,4).
MP usually presents in middle and late adulthood with
higher incidence in males. As it may be asymptomatic,
abdominal pain, fever, nausea, vomiting, diarrhea,
constipation, and weight loss can also occur in patients
(5). A poorly defined abdominal mass may be revealed
* Correspondence: dr.ali_3383@hotmail.com

during physical examination. Laboratory findings can be
normal or nonspecific such as elevation in the erythrocyte
sedimentation rate and white blood cell count and
decrease in the hemoglobin level (6). Most patients with
MP do not require any treatment. In symptomatic cases,
a combination of corticosteroids and tamoxifen may be
preferred for therapy (7).
With the increased use of abdominal imaging
modalities, MP is diagnosed incidentally with increasing
frequency during computed tomography (CT) imaging.
However, there are conflicting results about the prevalence
of MP and the reported prevalence rates range from
0.16% to 7.8% (8–12). CT is the most common diagnostic
method among imaging modalities. At least three out of
the following five typical signs are necessary for positive
CT diagnosis of MP: a well-defined mass composed of
inhomogeneous fatty tissue at the root of the small bowel
mesentery displacing neighboring intestinal structures
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with mass effect; lymph nodes in this mesenteric fat
tissue; increased attenuation in this area higher than
retroperitoneal fat; hypodense halo around the blood
vessels and nodes; hyperdense pseudocapsule surrounding
the mesenteric fat tissue (11,13).
The causes and pathogenesis of MP are still unclear,
but several possible causes have been postulated in the
literature (13–16). It is difficult to determine the precise
etiology of MP but it may be associated with various causes
such as autoimmune disease, granulomatous disease,
rheumatic disease, previous abdominal surgery, ischemia
of the mesentery, smoking, hypertension, urolithiasis, and
diabetes (13–16). MP has also been associated with various
malignant diseases including lymphoma, lung cancer,
melanoma, colon cancer, renal cell cancer, myeloma,
gastric carcinoma, chronic lymphocytic leukemia,
Hodgkin’s disease, large cell lymphoma, carcinoid tumor,
and thoracic mesothelioma (8–10). In such studies, the rate
of association with malignancy has varied between 17%
and 70% (8–16). For this reason, it has been suggested that
MP may be a paraneoplastic syndrome in some patients.
There are conflicting results about the prevalence of MP
and the role of malignant conditions in MP. In this study,
we aimed to determine the prevalence of MP, document
possible associated diseases, define the CT features of MP,
and find possible CT criteria to estimate the presence of
malignancy in 22,033 patients who underwent abdominal
CT.
2. Materials and methods
2.1. Study population
With a keyword search in our database, patients who
underwent abdominal CT and were diagnosed with
mesenteric panniculitis between September 2012 and
August 2016 were retrospectively researched. From
22,033 cases, 320 patients diagnosed with MP were
documented. The patients’ CT images were reevaluated
by two radiologists and the MP grades for each sign were
decided by consensus. Eleven patients were excluded from
the study due to acute pancreatitis (n = 3), ascites (n = 3),
portal vein thrombosis (n = 3), and superior mesenteric
vein thrombosis (n = 2). Therefore, 309 patients were
included in the study. The demographic characteristics,
accompanying diseases, surgical histories, medical
histories, and clinical indications of CT examinations
were recorded. The study was approved by the institutional
ethics committee.
2.2. CT protocol
All CT examinations were performed using a 160-slice
scanner (Toshiba Aquilion, Toshiba Medical Systems, Japan)
and a 16-slice scanner (SOMATOM Sensation 16, Siemens,
Forchheim, Germany) with axial 2-mm-thick
reconstruction images from diaphragm to pubic
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symphysis. All patients were examined using the standard
scanning protocol with intravenous and oral contrast
when it was indicated; however, contrast agents could not
be used in patients with renal failure, contrast allergy, or
kidney stones. Contrast-enhanced images were obtained
at the portal venous phase with a start delay of 70 s after
each patient received a total of 100–120 mL of nonionic
contrast agent and 30 mL of saline injection at a flow rate
of 4 mL/s. The CT protocol was as follows: 120 kVp, tube
current of 150–165 mAs, maximum 2.5 mm collimation,
slice thickness of 2 mm, and 0.5 s rotation time.
2.3. Analysis of CT images
The CT images were reevaluated by two radiologists and
the results were obtained by consensus. The diagnosis of
MP was reached using the following five diagnostic criteria:
a well-defined mass composed of inhomogeneous fatty
tissue without infiltration; increased attenuation; increased
number of lymph nodes; hypodense halo around the
blood vessels and nodes; and hyperdense pseudocapsule.
As Gögebakan et al. and Coulier classified, we described
four possible grades for each typical sign as follows: absent
(score 0), discrete (score 1), moderate (score 2), and
marked (score 3) (10,11). Because the diagnosis requires
at least three of these five CT signs, the minimum and
maximum total MP score were 3 and 15, respectively. MP
was classified as minimal (scores 3–4), moderate (scores
5–9), and marked (scores 10–15). CT findings including
the short and long diameters of the greatest lymph nodes
were recorded. In addition, the densities of mesenteric and
retroperitoneal fat were measured by circumscribing the
region of interest including at least 20 pixels. The vessels,
nodes, and intestinal structures were not included in the
measurement.
2.4. Statistical analysis
All of the data were analyzed using SPSS 13.0 (SPSS Inc.,
Chicago, IL, USA) and the MedCalc package (MedCalc
Statistical Software version 16.8, MedCalc Software bvba,
Ostend, Belgium). The means and ranges of age, density
of the inhomogeneous fatty mass and retroperitoneal
fat, and short and long diameters of the greatest lymph
node were calculated. The Kolmogorov–Smirnov test was
used to show deviation from normal distribution. The
nonparametric Mann–Whitney U test and parametric
Student’s t-test were used to compare the CT findings of
the patients with and without malignancy. The Mann–
Whitney U test was used to analyze age and the long
diameter of the greatest lymph node. Student’s t-test was
used to measure the short diameter of the greatest lymph
node and total MP score. Furthermore, the differences
between the attenuation values of the inhomogeneous
fatty mass and retroperitoneal fat were assessed using
a paired t-test. Optimal cut-off points of the short and
long diameters of the greatest lymph node and the total
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MP score for the probability of a malignancy were found
with using ROC analysis. If the obtained value was less
than the given cut-off value, the patient was considered
to have no malignancy. If not, the patient was considered
to have a malignancy. Sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV),
and accuracy of these parameters were calculated. The
area beneath the fitted binormal ROC curve (AUC) was
used to measure diagnostic efficacy. The AUC values were
calculated and compared with these parameters. P < 0.05
was considered to indicate a significant difference.
3. Results
In the present study, 22,033 patients underwent abdominal
CT; MP was detected in 309 of those patients (132 males,
177 females; age range: 18–87 years; mean age: 53 years)
with 1.4% prevalence. The main indications of the 22,033
patients in the initial CT were as follows: 10,157 followup or staging of malignancy (46.1%), 4583 abdominal
pain (20.8%), 2423 traffic accident (10.9%), 1828 suspicion
of ureterorenal stone (8.2%), 1652 falling from heights
(7.4%), 528 abnormal laboratory findings (2.3%), 194
abscess (0.9%), 181 suspicion of inflammatory bowel
disease (0.8%), and 487 other causes (2.2%). The main
indications of the 309 patients with MP in the initial CT
were as follows: 166 follow-up or staging of malignancy
(53.8%), 105 abdominal pain (34.0%), 32 follow-up
of known benign diseases (10.4%), and six abnormal
laboratory findings (1.9%). Of these patients, 233 (75.4%)
were evaluated using an initial contrast-enhanced CT and
76 (24.6%) were evaluated with noncontrast-enhanced
scans. Of the 309 patients with MP, 179 (57.9%) had
a malignancy and 130 (42.1%) did not have any known
malignancy in this study. The total MP score revealed
that 99 patients (32%) had mild MP, 151 (48.9%) patients
had moderate MP, and 59 (19.1%) patients had marked
MP (Figures 1–3). In addition, numbers of the mild,
moderate, and marked grades of patients with and without
a malignancy were mild grade: 31 and 68; moderate grade:
97 and 54, and marked grade: 51 and 8, respectively.
The mean ages of patients with and without malignancy
were 57 years (range: 22–87) and 48 years (range: 18–78),
respectively. The mean values of ages, short and long
diameters of the greatest lymph nodes, and total MP
scores for the patients with and without a malignancy
are shown in Table 1. The patients’ ages, short and long
diameters of the greatest lymph nodes, and total MP scores
were significantly higher in patients with a malignancy
compared to patients without a malignancy (P < 0.001).
The mean attenuation values of the inhomogeneous fatty
mass and retroperitoneal fat were –68.7 HU and –112.2
HU, respectively (P < 0.001).
The ROC curves of the short and long diameters of
the greatest lymph nodes and total MP scores are shown

Figure 1. A 43-year-old woman presented with abdominal pain;
the diagnosis included renal stones, left Bosniak type 1 renal
cortical cyst, and mild MP (score 3–4). The contrast-enhanced
axial CT image shows that the mesenteric fat is more hyperdense
(circle) than the retroperitoneal fat, with small lymph nodes
(square) and hypodense halo (arrow head) surrounding the
blood vessels and nodes.

Figure 2. A 53-year-old woman presented with abdominal pain;
the diagnosis was hepatic hemangioma, cholecystectomy due
to cholelithiasis, and moderate MP (score 5–9). The contrastenhanced axial CT image shows the hyperdense mesenteric
fat (circle), lymph nodes (square), hyperdense pseudocapsule
(diamond), and hypodense halo (arrow head) surrounding the
blood vessels and nodes.

in Figure 4. The AUCs were 0.728, 0.879, and 0.767 for
the short diameter, long diameter, and total MP scores,
respectively. The AUC of the long diameter was significantly
higher than the AUCs of the short diameter and total MP
scores (P < 0.001). The optimal cut-off values that provide
the highest sensitivity and specificity for the short and long
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Figure 3. A 41-year-old man with gastric cancer and a diagnosis
of marked MP (scores 10–15). The contrast-enhanced axial CT
image shows the hyperdense mesenteric fat (circle), lymph nodes
(square), hyperdense pseudocapsule (diamond), and hypodense
halo (arrow head) surrounding the blood vessels and nodes.

diameters and the total MP scores derived from the ROC
analysis were 5.0 mm, 11.7 mm, and 5.0, respectively. With
the use of these cut-off values, the obtained diagnostic
values for these parameters are presented in Table 2. The
highest diagnostic values obtained with the long diameter
of the greatest lymph nodes were 81.1% sensitivity, 76.1%
specificity, and 79.2% accuracy.
The most common malignancies recorded in 22,033
patients were gastric cancer (13.5%), breast cancer (12.7%),
colorectal cancer (11.4%), lymphoma (11.0%), prostate
cancer (7.7%), lung cancer (6.7%), pancreas cancer (5.9%),
bladder cancer (4.7%), ovarian cancer (4.5%), endometrial
cancer (3.8%), and other cancers (17.7%). Additionally, the
most common malignancies in 309 patients with MP were
lymphoma (9.3%), breast cancer (8.7%), endometrium
cancer (6.7%), ovarian cancer (5.8%), colorectal cancer
(4.2%), gastric cancer (3.2%), lung cancer (2.9%), renal cell
carcinoma (2.6%), and leukemia (2.6%). Of 179 patients,
58 had concurrent malignancies and 121 had a previous
malignancy. In 58 of the 130 patients with MP without

previous and/or concurrent malignancies, no reason
could be found for abdominal pain. The most common
accompanying benign disorders were as follows: ureteral
stones (n = 13), kidney stones (n = 9), cirrhosis (n = 4),
rheumatoid arthritis (n = 4), ulcerative colitis (n = 3),
colon diverticulum (n = 2), systemic lupus erythematosus
(n = 2), and acute appendicitis (n = 2). Of the 309 patients,
108 had a history of previous abdominal surgery for
different conditions, 100 had followed hypertension, 56
had previous coronary artery disease, and 57 had known
diabetes mellitus.
Of 124 patients, 112 with a malignancy and 12 without
a malignancy underwent one to eight follow-up abdominal
CTs between 1 month and 35 months from the initial CT
examinations. CT findings of MP were stable in all of the
patients. None of the 12 patients without a malignancy
developed a new malignancy during the follow-up period.
Six patients with malignancy developed a new malignancy
as follows: colon cancer (n = 2), breast cancer (n = 1),
endometrial cancer (n = 1), small bowel cancer (n = 1),
and ureteral transitional cell carcinoma (n = 1). None of
the patients were treated for MP and no biopsies were
performed.
4. Discussion
In the present study, we investigated the prevalence of MP,
possible associated diseases, and CT features of MP. Our
results showed that the prevalence of MP was 1.4% and
57.9% of these 309 patients had a concomitant malignancy.
We found that the total MP score and the short and long
diameters of the greatest lymph node could be useful in
estimating the presence of a malignancy. The total MP
score and the short and long diameters of the greatest
lymph node provided 71.1%, 67.9%, and 79.2% accuracy
for this purpose, respectively.
The prevalence of MP was found to be 1.4% in the
present study. Wilkes et al. in their study of 118 MP cases
reported that the prevalence of MP was 0.16%; however,
Daskalogiannaki et al. revealed that the prevalence of
MP was between 3.4% and 7.8% according to chosen CT
criteria in 613 patients with MP (8,9). The prevalence of

Table 1. Comparison of age and computed tomography features between patients with and without malignancy.
Patients with malignancy

Patients without malignancy

P-value

Total MP score

7.7 ± 2.9

5.1 ± 2.3

<0.001

Age (years)

56.5 ± 13.1

47.9 ± 14.8

<0.001

Short diameter of greatest lymph node (mm)

6.1 ± 1.8

4.7 ± 1.2

<0.001

Long diameter of greatest lymph node (mm)

14.5 ± 2.8

10.2 ± 2.2

<0.001

Values are mean values ± SD, P: significance level for all pairs.
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Figure 4. Graph shows the receiver operating characteristic
curve for the total MP score and the short diameters of the
greatest lymph node (SDGLN) and long diameters of the greatest
lymph node (LDGLN).

MP was usually reported at approximately 0.6% in other
studies (10). These diverse values may be due to changes
in the methods of patient documentation. In addition,
increased abdominal diagnostic imaging, knowledge of
specific signs of MP, and radiologist awareness may be
causes for the increasing prevalence of MP. In our study,
there was a female dominance with a 1.34 to 1 female to
male ratio. Although male predominance was reported
in most studies, Daskalogiannaki et al. showed female
dominance with a 1.8 to 1 female to male ratio (8). The
mean age at diagnosis of MP was 53 years, which is
compatible with reported studies in the literature (5,6).
In our study, the total MP scores revealed that 99
patients (32%) had mild MP, 151 (48.9%) patients had
moderate MP, and 59 (19.1%) patients had marked MP.

Although mild MP was more common in patients without
a malignancy, marked MP was highly observed in patients
with a malignancy. Coulier and Gögebakan et al. reported
that the mild, moderate, and marked grades of MP were
29%, 58%, and 13%, respectively (10,11). In addition, it
was reported that patients were classified as having mild
MP in 10.4% of cases, moderate MP in 58.3% of cases, and
marked MP in 29.1% of cases (11).
Gögebakan et al. and Coulier reported that there
was no difference between the mean total MP scores of
patients with and without a malignancy (10,11). However,
we found that total MP scores for the patients with and
without malignancy were 7.7 and 5.1, respectively. There
were also statistically significant differences between
these two groups (P < 0.001). We thought that it might
be due to the differences between the patients’ population
distribution. The optimal cut-off level of the total MP score
for estimating the presence of a malignancy was 5.0. The
obtained sensitivity, specificity, and accuracy of the total
MP score were 70.3%, 72.3%, and 71.1%, respectively.
Also, the mean short and long diameters of the greatest
lymph node were statistically higher in patients with a
malignancy than those without a malignancy (P < 0.001).
The obtained sensitivity, specificity, and accuracy of the
short and long diameters of the greatest lymph node were
69.2% and 81.1%, 65.3% and 76.1%, and 67.9% and 79.2%,
respectively. In the present study, we found that the long
diameter of the greatest lymph node was significantly more
effective than the short diameter of the greatest lymph
node and total MP score for estimating the presence of a
malignancy.
There are inconsistent results in the literature about
the relationship between malignancies and MP. Several
studies reported that the rate of malignancy associated
with MP varied between 17% and 70% (8–16). Of 309
patients, 179 (57.9%) had an accompanying malignancy in
the present study. MP is usually seen later in adult life; in
our study, the mean age at diagnosis was 53 years. Also,
we found that the mean age of patients with a malignancy
was significantly higher than that of patients without a

Table 2. Results of receiver operating characteristic analysis for total mesenteric panniculitis score and short and long diameters of the
greatest lymph node.
AUC
Total MP score

Cut-off level Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)

0.767 5

70.3

72.3

77.8

63.9

71.1

Short diameter of greatest lymph node

0.728 5.0 mm

69.2

65.3

73.4

63.7

67.9

Long diameter of greatest lymph node

0.879 11.7 mm

81.1

76.1

82.4

74.4

79.2

MP: Mesenteric panniculitis, AUC: area under curve, PPV: positive predictive value, NPV: negative predictive value.
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malignancy. This difference may be due to the increasing
probability of cancer development with age. Additionally,
the main purpose of abdominal CT in oncology centers
is to diagnose and stage the cancer. In our opinion, these
factors can change the relationship between MP and
malignancies in studies.
Several studies reported that the most common
malignancies accompanying MP were lymphoma,
prostate cancer, lung cancer, melanoma, colon cancer, and
gastric cancer (8–15). In the present study, most of the
patients with MP (57.9%) were commonly suffering from
lymphoma, breast cancer, endometrium cancer, ovarian
cancer, colorectal cancer, and lung cancer. Lymphoma for
Daskalogiannaki et al., colorectal cancer for Gögebakan
et al., prostate cancer for Coulier, and prostate cancer for
van Putte-Katier et al. were the most frequent coexisting
malignancies (8,10,11,15). Of 179 patients, 58 had
concurrent malignancies and 121 had a previous known
malignancy at the time of MP diagnosis. We did not have
access to previous abdominal CT examinations so we did
not know whether or not the MP occurred before or after
a malignancy. Abdominal surgery, autoimmune disease,
granulomatous disease, rheumatic disease, ischemia of
the mesentery, smoking, hypertension, urolithiasis, and
diabetes are also other causes of MP (13,16). In our study,
34.9% of the patients underwent abdominal surgery for
various conditions, 32.3% of them had hypertension,
18.4% of them had diabetes, 18.1% of them coronary artery
disease, 7.1% of them had ureterorenal stone, and 1.9% of
them had autoimmune disease. However, we could not
evaluate the time interval between surgery and abdominal
CT acquisition time and smoking addiction, which were
not documented in the patients’ clinical records.
The causes, pathogenesis, and mechanism related to
malignancy of MP are still unclear. Kipfer et al. reported
that MP is a nonspecific response to an underlying
malignancy (17). Wilkes et al. in their study with 38%
prevalence of malignancy suggested that MP could be an
occult condition that might give rise to a malignancy over
the years (9). Because of the relationship by up to 70% with
malignancy, MP may be seen as a paraneoplastic syndrome
in some patients.
The increase in the attenuation of mesenteric fat, also
called misty mesentery, is one of the CT signs of MP (14).
However, several conditions can change the attenuation
of mesenteric fat such as early-stage lymphoma, carcinoid
tumor, mesenteric hemorrhage, mesenteric inflammation
and mesenteric edema due to cirrhosis, portal hypertension,
and hepatic, portal, or mesenteric vein thrombosis (18). In
our study, eleven patients were excluded from the study
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due to acute pancreatitis (n = 3), ascites (n = 3), portal
vein thrombosis (n = 3), and superior mesenteric vein
thrombosis (n = 2). In such cases, CT examination may be
useful for evaluating mesenteric attenuation changes and
detecting underlying causes.
In the present study, the following were the most
common causes for CT examinations: follow-up or staging
of a malignancy (53.8%), abdominal pain (34.0%), followup for known benign diseases (10.4%), and abnormal
laboratory findings (1.9%). Abdominal pain was a more
frequent clinical symptom in the patients, especially those
patients without a malignancy. The fatty mass at the root
of the mesentery displacing the bowel, blood vessels, and
lymphatics may be associated with abdominal pain (19).
Because the detected cause of abdominal pain was MP in
some of our patients, especially those without malignancy,
MP may be the cause of abdominal pain in emergency
departments.
Of our patients, 124 underwent follow-up abdominal
CT between 1 and 35 months from the initial CT
examinations. While none of the 12 patients without a
malignancy developed a new malignancy, six patients
with a malignancy suffered from one of the following new
malignancies: colon cancer (n = 2), breast cancer (n = 1),
endometrial cancer (n = 1), small bowel cancer (n = 1),
and ureteral transitional cell carcinoma (n = 1). MP usually
has a self-limiting process and good prognosis. Although
Akram et al. reported up to 20% clinical deterioration in
their study, the stability of CT findings has usually been
described as in our study (19). The CT findings of MP were
stable in all of our patients.
This study has a number of limitations. First, we did
not evaluate inter- and intraobserver variability. Second,
the diagnosis of MP was acquired with only CT findings
and none of the patients had a histopathological diagnosis
of MP. Third, there were not enough patients to investigate
the effectiveness of CT findings for estimating the presence
of a malignancy on subtypes of benign and malignant
diseases. Finally, there was a lack of long-term follow-up
results and a matched control group to compare probable
confounding factors such as age and sex.
In conclusion, increased abdominal imaging modalities
and radiologist awareness are related to increased
diagnosis of MP. With an increased number of studies, MP
is generally thought to be associated with abdominal and
distal system malignancies, so it may be a paraneoplastic
syndrome in some patients. However, extensive studies
with larger populations are needed to clearly document
the relationship between malignancy and MP, especially in
patients without a malignancy.
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